Glaucoma is a group of diseases characterized by an optic neuropathy with progressive retinal ganglion cell death. Elevated intraocular pressure (IOP) is a major risk factor for glaucoma. The balance between the secretion of aqueous humor and its drainage impacts the IOP.
1 In primary open-angle glaucoma (POAG), there is resistance to aqueous outflow through the trabecular meshwork, whereas in primary angle closure glaucoma (PACG), the access to the trabecular meshwork is typically obstructed by apposition of the iris. The iris is also implicated in the pathophysiology of glaucoma through alterations in its biomechanical properties and fluid conductivity.
2 Altered biomechanical function of the iris exhibits itself as increased mechanical stiffness in the PACG iris,
3,4 which has been demonstrated in PACG irises both ex vivo
5 and in vivo,
6 in association with a reduction in iris volume/area changes in response to pupil dilation.
7–9 This property of the PACG iris may be correlated with increase in extracellular matrix gene expression in the iris.
10,11 Fluid conductivity is also central to iris function, enabling the iris to respond rapidly to light via rapid loss of water from the compressible
12 and porous spongelike iris stroma
13 to the anterior chamber.
8 In addition, being the only tissue in the anterior chamber with a vascular network, the iris can facilitate the direct exchange of extracellular fluid from the systemic circulation into the anterior chamber via osmotic gradients, with the potential to affect the IOP. This is clinically evidenced by hypotonicity of the blood osmotic pressure inducing a rise in IOP (e.g., in the water-drinking test
14) and hypertonicity inducing a fall in IOP (e.g., during administration of oral glycerol,
15 intravenous mannitol,
16 or intravenous hypertonic saline solution).
17 Although alterations in iris fluid conductivity are suspected to play a role in glaucoma pathophysiology,
2,18 its molecular basis has not been established.